Matching articles for "Amrix"
Sublingual Cyclobenzaprine (Tonmya) for Fibromyalgia
The Medical Letter on Drugs and Therapeutics • January 19, 2026; (Issue 1746)
The FDA has approved Tonmya (Tonix), a sublingual
tablet formulation of the skeletal muscle relaxant
cyclobenzaprine, for treatment of fibromyalgia in
adults. Cyclobenzaprine is available in...
The FDA has approved Tonmya (Tonix), a sublingual
tablet formulation of the skeletal muscle relaxant
cyclobenzaprine, for treatment of fibromyalgia in
adults. Cyclobenzaprine is available in immediate-release
tablets and extended-release capsules for
short-term treatment of muscle spasms and has been
used off-label for treatment of fibromyalgia.
Extended-Release Cyclobenzaprine (Amrix)
The Medical Letter on Drugs and Therapeutics • December 17, 2007; (Issue 1276)
An extended-release formulation of the centrally-acting muscle relaxant cyclobenzaprine (Amrix - Cephalon) has been approved by the FDA for treatment of muscle spasms. Immediate-release (IR) cyclobenzaprine...
An extended-release formulation of the centrally-acting muscle relaxant cyclobenzaprine (Amrix - Cephalon) has been approved by the FDA for treatment of muscle spasms. Immediate-release (IR) cyclobenzaprine (Flexeril, and others) has been available since 1977.